0000000000889117

AUTHOR

Jacob Fernández-gallardo

showing 12 related works from this author

Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains.

2014

A series of new heterometallic gold(I) thiolates containing ferrocenyl-phoshines were synthesized. Their antimicrobial properties were studied and compared to that of FDA-approved drug, auranofin (Ridaura), prescribed for the treatment of rheumatoid arthritis. MIC in the order of one digit micromolar were found for most of the compounds against Gram-positive bacteria Staphylococcus aureus and CA MRSA strains US300 and US400. Remarkably, auranofin inhibited S. aureus, US300 and US400 in the order of 150-300 nM. This is the first time that the potent inhibitory effect of auranofin on MRSA strains has been described. The effects of a selected heterometallic compound and auranofin were also stu…

Methicillin-Resistant Staphylococcus aureusStaphylococcus aureusAuranofinMicrobial Sensitivity Testsmedicine.disease_causeCrystallography X-RayBiochemistryArticleMicrobiologyInorganic ChemistryAuranofinmedicineHumansInhibitory effectbiologyChemistryAntimicrobialbiology.organism_classificationMethicillin-resistant Staphylococcus aureusKidney cellAnti-Bacterial AgentsHEK293 CellsStaphylococcus aureusOrganogold CompoundsBacteriamedicine.drugJournal of inorganic biochemistry
researchProduct

Versatile synthesis of cationic N-heterocyclic carbene–gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium–g…

2016

We describe a versatile and quick route to cationic gold(i) complexes containing N-heterocyclic carbenes and a second ancillary ligand (such as phosphanes, phosphites, arsines and amines) of interest for the synthesis of compounds with potential catalytic and medicinal applications. The general synthetic strategy has been applied in the preparation of novel cationic heterobimetallic ruthenium(ii)-gold(i) complexes that are highly cytotoxic to renal cancer Caki-1 and colon cancer HCT 116 cell lines while showing a synergistic effect and being more selective than their monometallic counterparts.

Stereochemistrychemistry.chemical_elementLigands010402 general chemistry01 natural sciencesArticleRutheniumCatalysisCatalysischemistry.chemical_compoundHeterocyclic CompoundsCationsMaterials Chemistry010405 organic chemistryChemistryLigandSecond ancillaryMetals and AlloysCationic polymerizationGeneral ChemistryCombinatorial chemistry0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsRutheniumCeramics and CompositesGoldMethaneCarbeneChemical Communications
researchProduct

Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo

2015

Following recent work on heterometallic titanocene-gold complexes as potential chemotherapeutics for renal cancer, we report here on the synthesis, characterization and stability studies of new titanocene complexes containing a methyl group and a carboxylate ligand (mba = S-C6H4-COO-) bound to gold(I)-phosphane fragments through a thiolate group ([(η-C5H5)2TiMe(μ-mba)Au(PR3)]. The compounds are more stable in physiological media than those previously reported and are highly cytotoxic against human cancer renal cell lines. We describe here preliminary mechanistic data involving studies on the interaction of selected compounds with plasmid (pBR322) DNA used as a model nucleic acid, and with s…

BiochemistryChemistryKinaseCell cultureIn vivoCancer cellCytotoxic T cellGeneral ChemistryLigand (biochemistry)Protein kinase BIn vitro3. Good healthChemical Science
researchProduct

Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo † †This paper is dedicated to Prof. Roberto Sánchez-Delgado, g…

2015

Heterometallic compounds as anticancer agents demonstrating in vivo potential for the first time. Titanocene–gold derivatives: promising candidates for renal cancer.

ChemistryChemical Science
researchProduct

Titanocene–gold complexes containing N-heterocyclic carbene ligands inhibit growth of prostate, renal, and colon cancers in vitro

2016

We report on the synthesis, characterization, and stability studies of new titanocene complexes containing a methyl group and a carboxylate ligand (mba = −OC(O)-p-C6H4-S−) bound to gold(I)−N-heterocyclic carbene fragments through the thiolate group: [(η5 -C5H5)2TiMe(μ-mba)Au(NHC)]. The cytotoxicities of the heterometallic compounds along with those of novel monometallic gold−N-heterocyclic carbene precursors [(NHC)Au(mbaH)] have been evaluated against renal, prostate, colon, and breast cancer cell lines. The highest activity and selectivity and a synergistic effect of the resulting heterometallic species was found for the prostate and colon cancer cell lines. The colocalization of both tita…

010405 organic chemistryLigandStereochemistryOrganic Chemistry010402 general chemistrymedicine.disease01 natural sciencesArticleIn vitro3. Good health0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundProstate cancermedicine.anatomical_structurechemistryProstatemedicineCarboxylatePhysical and Theoretical ChemistryQD0146SelectivityCarbeneMethyl group
researchProduct

Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties

2014

Early–late transition metal TiAu2 compounds [(η-C5H5)2Ti{OC(O)CH2PPh2AuCl}2] (3) and new [(η-C5H5)2Ti{OC(O)-4-C6H4PPh2AuCl}2] (5) were evaluated as potential anticancer agents in vitro against renal and prostate cancer cell lines. The compounds were significantly more effective than monometallic titanocene dichloride and gold(I) [{HOC(O)RPPh2}AuCl] (R = −CH2– 6, −4-C6H4– 7) derivatives in renal cancer cell lines, indicating a synergistic effect of the resulting heterometallic species. The activity on renal cancer cell lines (for 5 in the nanomolar range) was considerably higher than that of cisplatin and highly active titanocene Y. Initial mechanistic studies in Caki-1 cells in vitro couple…

Cisplatin010405 organic chemistryKinaseChemistryStereochemistryOrganic ChemistryCancerTitanocene dichlorideNanotechnology010402 general chemistrymedicine.disease01 natural sciencesArticleIn vitro0104 chemical sciences3. Good healthInorganic Chemistrychemistry.chemical_compoundGold CompoundsmedicinePhysical and Theoretical ChemistryProtein kinase AProtein kinase Bmedicine.drugOrganometallics
researchProduct

CCDC 977988: Experimental Crystal Structure Determination

2014

Related Article: Yozane Hokai, Boruch Jurkowicz, Jacob Fernández-Gallardo, Nuruddinkodja Zakirkhodjaev, Mercedes Sanaú, Theodore R. Muth, María Contel|2014|J.Inorg.Biochem.|138|81|doi:10.1016/j.jinorgbio.2014.05.008

(mu-11'-bis(diphenylphosphino)ferrocene)-bis(benzenethiolato)-di-goldSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1436326: Experimental Crystal Structure Determination

2016

Related Article: Jacob Fernández-Gallardo, Benelita T. Elie, Mercedes Sanaú, María Contel|2016|Chem.Commun.|52|3155|doi:10.1039/C5CC09718E

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersdichloro-(13-dimesityl-23-dihydro-1H-imidazol-2-ylidene)-(mu-((diphenylphosphino)methyl)(diphenyl)phosphine)-(1-isopropyl-4-methylbenzene)-ruthenium-gold perchlorate dichloromethane solvateExperimental 3D Coordinates
researchProduct

CCDC 977989: Experimental Crystal Structure Determination

2014

Related Article: Yozane Hokai, Boruch Jurkowicz, Jacob Fernández-Gallardo, Nuruddinkodja Zakirkhodjaev, Mercedes Sanaú, Theodore R. Muth, María Contel|2014|J.Inorg.Biochem.|138|81|doi:10.1016/j.jinorgbio.2014.05.008

Space GroupCrystallographyCrystal System(mu-11'-bis(diphenylphosphino)ferrocene)-bis(45-dihydro-13-thiazole-2-thiolato)-di-goldCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1436327: Experimental Crystal Structure Determination

2016

Related Article: Jacob Fernández-Gallardo, Benelita T. Elie, Mercedes Sanaú, María Contel|2016|Chem.Commun.|52|3155|doi:10.1039/C5CC09718E

Space GroupCrystallographyCrystal SystemCrystal Structure(13-bis(26-diisopropylphenyl)-23-dihydro-1H-imidazol-2-ylidene)-dichloro-(mu-((diphenylphosphino)methyl)(diphenyl)phosphine)-(1-isopropyl-4-methylbenzene)-ruthenium-gold perchlorate unknown solvateCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1008332: Experimental Crystal Structure Determination

2014

Related Article: Jacob Fernández-Gallardo, Benelita T. Elie, Florian J. Sulzmaier, Mercedes Sanaú, Joe W. Ramos, María Contel|2014|Organometallics|33|6669|doi:10.1021/om500965k

Space GroupCrystallographyCrystal Systembis(mu2-Diphenylphosphinoacetato)-dichloro-bis(eta5-cyclopentadienyl)-di-gold-titanium chloroform solvateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1400886: Experimental Crystal Structure Determination

2015

Related Article: Jacob Fernández-Gallardo, Benelita T. Elie, Tanmoy Sadhukha, Swayam Prabha, Mercedes Sanaú, Susan A. Rotenberg, Joe W. Ramos, María Contel|2015|Chemical Science|6|5269|doi:10.1039/C5SC01753J

Space GroupCrystallographyCrystal System(4-carboxybenzene-1-thiolato)-((ferrocen-1-yl)(diphenyl)phosphine)-gold(i)Crystal StructureCell ParametersExperimental 3D Coordinates
researchProduct